🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
This is a phase 2 study to investigate the safety and efficacy of PAC-14028...
Status
Completed
Location
Chung-ang University Hospital
Start Date
2015-10
Trial ID
NCT02757729
Treatments Being Tested
This is a phase II, double blind study with ZEP-3NA 0.1% or 1% vs. vehicle-...
Status
Unknown
Location
Ha'Emek MC
Start Date
2019-12-29
Trial ID
NCT04307862
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of two dos...
Status
Completed
Location
Clinical Research Site
Start Date
2004-09
Trial ID
NCT00373516
This is a Phase 2, multi-center, randomized, double-blind, placebo-controll...
Status
Recruiting
Location
The Center for Vulvovaginal Disorders - Washington, DC
Start Date
2026-01-02
Trial ID
NCT07257029
Treatments Being Tested
This is a double-blind, multicenter study to assess the efficacy and safety...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00539929
Treatments Being Tested
Fluorouracil is recommended for the topical treatment of multiple actinic o...
Status
Completed
Location
CBCC Global Research Site 005
Start Date
2022-03-01
Trial ID
NCT05078827
Part I was a double-blind, randomized, vehicle-controlled Proof of Concept ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-07
Trial ID
NCT00961896
Treatments Being Tested
The aim of this trial is to assess the efficacy of 0417 Ointment in the Tre...
Status
Completed
Location
Fougera Pharmaceuticals Inc.
Start Date
2008-01
Trial ID
NCT01139450
Treatments Being Tested
This is a double-blind, dose escalating, randomized, vehicle-controlled stu...
Status
Completed
Location
12121 Bluff Creek Drive Suite 100
Start Date
2016-11-11
Trial ID
NCT02828111
Treatments Being Tested